Meridian Clinical Research, a leading multi-specialty site network, has hired Michelle Hurst as Director of Operational Project Management. In her role, Hurst will focus on optimizing performance and operational continuity across Meridian’s 23 sites. Before joining Meridian, Hurst was Director of Clinical Research at McKesson’s Intrafusion Research Network. At Intrafusion, Hurst developed and directed … Read more
On behalf of the Meridian team, we want to wish you and your family a safe and happy holiday season. We also want to thank you for an incredible year. 2020 began with great uncertainty. It ends with greater optimism. All at once, COVID-19 disrupted many ongoing trials while also thrusting clinical research and vaccine … Read more
Meridian Clinical Research, a leading multi-specialty investigative research network, has opened a dedicated research center at 4802 Sunnybrook Drive in Sioux City, IA. Since 2005, Meridian has conducted clinical trials at a site in Dakota Dunes, SD. All Dakota Dunes personnel and studies will be moved to the new site in Sioux City, where … Read more
Meridian Clinical Research, a leading investigative research network, has finished enrolling participants into Moderna’s Phase 3 clinical trial for mRNA-1273, its COVID-19 vaccine candidate. Today, Moderna reached its goal of 30,000 participants for the Phase 3 clinical trial. Meridian conducted the study at eight of its sites, and enrolled more than 2,750 participants into … Read more
Officials from the U.S. Department of Health and Human Services (HHS) visited with leaders from Meridian Clinical Research in Savannah, GA. Following a tour of Meridian’s internal medicine site in Savannah, the group held a roundtable to discuss Meridian’s patient recruitment efforts and the research the company has conducted for COVID-19 vaccine clinical trials. Attendees … Read more
Meridian Clinical Research, a leading investigative research network, won the 2020 Vaccine Industry Excellence (ViE) award for Best Clinical Trial Site. Meridian is also the largest member of Platinum Research Network, which won the ViE award for Best Clinical Trial Network. “It’s incredible to earn these awards when vaccine trials are the industry’s priority … Read more
Inc. magazine ranked Meridian Clinical Research as 2,938 on its annual Inc. 5000 list, the most prestigious ranking of the nation’s fastest-growing private companies. Headquartered in Omaha, NE, Meridian is a multi-specialty site network with 24 sites nationwide. “It’s an honor to be recognized,” said Nicole Osborn, Meridian founder and CEO. “Our goal has … Read more
Meridian Clinical Research announced today it has begun recruiting healthy adults for a Phase 3 clinical research study to evaluate the safety and effectiveness of mRNA-1273, a vaccine candidate against COVID-19. Sponsored by Moderna, the COVE Study is recruiting healthy volunteers ages 18 or older in high-risk populations, including the elderly, racial and ethnic … Read more
Leaders of the Operation Warp Speed (OWS) program visited Meridian Clinical Research’s internal medicine site in Savannah, GA. Visitors included Moncef Slaoui, chief advisor, and General Gustave F. Perna, chief operating officer, of OWS. In May, the federal government announced the OWS program to accelerate the development, manufacturing, and distribution of COVID-19 vaccines, therapeutics, … Read more
The first participant in the Moderna Phase III COVID-19 vaccine trial was enrolled this morning by Dr. Paul Bradley, Principal Investigator at Meridian’s internal medicine site in Savannah, GA. Compliments to Moderna on this significant milestone for its mRNA vaccine candidate (mRNA-1273) against COVID-19. 📰 Full release: https://investors.modernatx.com/news-releases/news-release-details/moderna-announces-phase-3-cove-study-mrna-vaccine-against-covid
Brandon Essink, MD, CPI, is a co-principal investigator for the Phase III clinical trial of Moderna’s COVID-19 vaccine. Read the full National Institutes of Health (NIH) press release: https://www.nih.gov/news-events/news-releases/phase-3-clinical-trial-investigational-vaccine-covid-19-begins
Meridian Clinical Research, a leading multi-specialty investigative research network, has opened new sites in Grand Island, NE, and Hastings, NE. Meridian is partnering with Adam Brosz, MD, Erica Haake, MD, and Timothy Gardner, MD, in Grand Island. The physicians will serve as principal investigators to conduct clinical trials related to general medicine, women’s health, … Read more
The first participant in the Moderna Phase II COVID-19 vaccine trial was enrolled morning by Keith Vrbicky, MD, Meridian Principal Investigator in Norfolk, NE. Congratulations to Moderna for making remarkable progress on its mRNA vaccine against novel coronavirus. 📰 Full release: https://investors.modernatx.com/news-releases/news-release-details/moderna-announces-first-participants-each-age-cohort-dosed-phase
Meridian Clinical Research, a leading investigative research network, is seeking participants for COVID-19 vaccine clinical trials in the following areas: Nebraska (Norfolk and Omaha), Georgia (Savannah), and South Dakota (Dakota Dunes). The studies will help determine the safety and efficacy of investigational vaccines intended to protect against SARS-CoV-2 (the coronavirus that causes COVID-19). To … Read more
Andrew Kimball, vice president, business development (BD), recently published an article in SCRS InSite that highlights the importance of BD at research sites and networks. The article outlines BD’s role in enhancing feasibility processes, opportunity sourcing, and the nurturing of long-term partnerships with Sponsors and CROs. ? Full article: https://cloud.3dissue.com/180561/181052/211361/SpringInsite2020/index.html?page=6
Meridian Clinical Research, a leading investigative research network, will remain open to support the research of investigational tests, vaccines, and medications intended for commercial release. Meridian sites are working with Sponsors and contract research organizations (CROs) to ensure patient safety while continuing to enroll patients during the COVID-19 pandemic. The company has enrolled more … Read more
Meridian Clinical Research, a leading investigative research network, is a finalist to win the 2020 Vaccine Industry Excellence (ViE) award for Best Clinical Trial Site. Meridian is also the largest member of Platinum Research Network, which is a finalist for the Best Clinical Trial Network award. These nominations were the result of two voting … Read more
Omaha, Neb., December 17, 2019 — Meridian Clinical Research, a leading investigative research network, has donated more than $290,000 to people in need, fundraisers, and charitable organizations in 2019. The amount was accumulated through a novel employee incentive program that intertwines annual bonus and charitable giving budgets. “Our communities and our patients are at … Read more
Three Meridian principal investigators were voted Best of Savannah Doctors 2019 by Savannah Magazine readers. The award winners include: Buffi G. Boyd, MD, of Urological Associates of Savannah, PC for Best Urologist Corinne Howington, MD, of Low Country Dermatology for Best Dermatologist Michael Hemphill, MD, of Savannah Neurology Specialists for Best Neurologist Read Savannah Magazine’s Best of Savannah … Read more
Meridian Clinical Research, a leading investigative research network, is celebrating its twentieth year in business. Meridian was founded by Nicole Osborn, the company’s CEO, in 1999. It began as a single research site in Omaha, Neb., where the company is headquartered. Meridian added locations in Norfolk, Neb., and Dakota Dunes, S.D., before establishing a … Read more
Find a Study
When people like you participate in a clinical trial, we can uncover better ways to treat conditions that may affect you and your loved ones. Sign up for more information about clinical trials near you: mcrmed.com/find-study